Skip to main content

Table 1 Baseline characteristics of ischemic stroke patients according to adherence to a Mediterranean diet using MEDAS score

From: Pre-stroke adherence to a Mediterranean diet pattern is associated with lower acute ischemic stroke severity: a cross-sectional analysis of a prospective hospital-register study

Variable

High adherence

N (%)

151 (41)

Low adherence

N (%)

217 (59)

Total

N (%)

368 (100)

P Value

Age, years, mean (SDa)

69.9 (16.9)

67.2 (18.7)

68.3 (17.7)

0.1

Gender (female)

66 (43.7)

92 (42.4)

158 (42.9)

0.8

Hypertension

89 (58.9)

133 (61.3)

222 (60.3)

0.5

Diabetes Mellitus

17 (11.2)

41 (18.9)

58 (15.7)

0.04

Insulin resistance

15 (9.9)

17 (7.8)

32 (8.7)

0.4

Dyslipidemia

56 (37.0)

67 (30.8)

123 (33.4)

0.2

Coronary artery disease

20 (13.2)

28 (9.21)

48 (13.0)

0.7

Atrial fibrillation

26 (17.2)

40 (18.4)

66 (17.9)

0.7

Prior stroke

27 (17.9)

36 (16.6)

63 (17.1)

0.7

Chronic Renal Failure

8 (5.3)

21 (9.7)

29 (7.9)

0.1

Mood disorder

19 (12.6)

32 (14.7)

51 (13.8)

0.5

Current smoker

34 (22.5)

46 (21.2)

80 (21.7)

0.2

Alcohol consumption

76 (50.3)

83 (38.4)

159 (43.3)

0.02

Sedentary lifestyle

90 (59.6)

172 (79.3)

262 (71.2)

< 0.001

Previous dependencyb

11 (7.3)

29 (13.4)

40 (10.9)

0.06

Time from symptom onset to admission, median (IQRc)

165 (72–706)

248 (78–1385)

228 (68–784)

0.03

Admission Systolic Blood Pressure, mean (SD)

148 (25.0)

151 (26.2)

150 (25.7)

0.1

Admission Diastolic Blood Pressure, mean (SD)

80.9 (15.1)

83.3 (17.6)

83.3 (16.6)

0.1

Admission body mass index, Mean (SD)

25.1 (3.4)

26.7 (4.4)

26.0 (4.1)

0.001

Admission NIHSSd median (IQR)c

2-(1-6)

4 (2-11)

3 (1-7)

0.0006

Vessel occlusion

45 (29.8)

72 (33.2)

117 (31.8)

0.5

Intravenous thrombolysis use

53 (35.19

78 (35.9)

131 (35.6)

0.8

Intra-arterial thrombectomy

18 (11.9)

20 (9.0)

38 (10.3)

0.4

Large-artery atherosclerosis

29 (19.1)

47 (21.7)

76 (20.7)

0.5

Cardioembolic

48 (31.7)

62 (28.7)

110 (29.29)

0.5

Dissection

11 (7.2)

18 (8.3)

29 (7.9)

0.7

Other determined

10 (6.2)

14 (6.4)

24 (6.5)

0.9

Cryptogenic (complete work-up)

48 (31.8)

52 (23.9)

100 (27.1)

0.09

Undetermined (incomplete work-up)

3 (1.9)

6 (2.7)

9 (2.4)

0.6

Not classifiable (2 or more causes)

4 (2.6)

14 (6.4)

18 (4.9)

0.09

Glucose, (mg/dl), mean

117.3 (35.6)

124.9 (47.6)

121.7 (43.1)

0.07

Total cholesterol, (mg/dl), mean

157.3 (45.8)

169.2 (47.4)

164.1 (46.9)

0.02

LDLe cholesterol, (mg/dl), mean

99.2 (38.8)

110.9 (43.4)

105.9 (42.1)

0.01

HDLf cholesterol, (mg/dl), mean

48.6 (14.8)

47.2 (15.2)

48.1 (15.0)

0.6

Triglycerides, (mg/dl), mean

130.7 (111.9)

138.4 (82.6)

135.1 (96.3)

0.2

HbA1cg (%), median (IQRc)

5.6 (5.3–6.0)

5.6 (5.3–6.0)

5.6 (5.3–6.0)

0.8

Hemoglobin, (g/dl), mean

13.9 (1.7)

13.7 (2.1)

13.8 (1.9)

0.5

Leucocyte count

2639 (4479)

2643 (4439)

2641 (4449)

0.9

  1. aSD standard deviation, bmRS (modified Rankin Scale) = 3–5, cIQR interquartile range, dNIHSS National Institutes of Health Stroke Scale, eLDL Low-Density Lipoprotein, fHDL High-density Lipoprotein, gHbA1c glycosylated haemoglobin A1c